Does Lyrica Interfere with EMG Results?
There is no evidence that Lyrica (pregabalin) interferes with standard electromyography (EMG) results used for diagnosing neuromuscular disorders. The available literature does not demonstrate any neuropharmacological effects of pregabalin on EMG findings, and the FDA label does not list EMG interference as a known effect of the medication.
Evidence Base
The most relevant guideline evidence comes from a comprehensive neurolaryngology study group review that specifically searched for medication effects on electromyography. Their systematic literature search for "medication + laryngeal + electromyography" and "drug + laryngeal + electromyography" found no human studies examining neuropharmacological effects on EMG 1. While this guideline focused on laryngeal EMG, the fundamental principles of electromyographic recording apply across muscle groups.
The FDA drug label for Lyrica extensively documents adverse effects across multiple body systems but does not mention any interference with electrodiagnostic testing or EMG results 2. The label does note neurological side effects including dizziness, somnolence, ataxia, and tremor, but these are clinical symptoms rather than alterations in electrophysiological recordings.
Clinical Context and Neurophysiological Effects
While pregabalin does not interfere with EMG recordings themselves, it's important to understand what the drug does affect:
- Pregabalin can cause clinical neurological symptoms including tremor (1-8% of patients), myoclonus, ataxia, and incoordination 2, 3
- These are observable clinical phenomena, not artifacts in EMG recordings
- Case reports document pregabalin-induced myoclonus that was confirmed by polygraphic EMG studies, demonstrating that EMG can accurately capture pregabalin-related movement disorders 4, 3
In one particularly relevant case, a patient with stiff-person syndrome showed dramatic changes in EMG findings after pregabalin treatment - continuous motor unit activity at rest disappeared and cortical silent period prolonged 5. This demonstrates that pregabalin's therapeutic effects can be objectively measured by EMG, further confirming that the drug does not interfere with the recording technique itself.
Important Caveats
Do not confuse clinical side effects with EMG interference:
- If a patient develops pregabalin-induced tremor or myoclonus, the EMG will accurately record these abnormal movements
- This represents true pathophysiology, not technical interference with the test
- The EMG remains a valid diagnostic tool even in patients taking pregabalin
Patient cooperation may be affected:
- Pregabalin causes somnolence in 12-16% of patients and dizziness in 21-29% 2
- These side effects could theoretically impair patient cooperation during EMG testing
- However, this is a patient performance issue, not a technical interference with the EMG equipment or interpretation
Practical Recommendations
You do not need to discontinue pregabalin before performing EMG studies. The medication will not create false-positive or false-negative results in the evaluation of:
- Nerve conduction studies
- Needle EMG for denervation or myopathy
- Motor unit action potential analysis
- Recruitment patterns
Document pregabalin use in the clinical history because if the patient has developed drug-induced movement disorders (tremor, myoclonus), these will appear on the EMG as real findings that may require clinical correlation.